Not specified
This page covers all Not specified drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Not specified, EGFR Exon 20 Insertion Mutations.
Targets
Not specified · EGFR Exon 20 Insertion Mutations
Marketed (22)
- Immuno-oncology (IO) · Pfizer · Oncology · 1301
- Pf-06882961 · Pfizer · Oncology
Not specified - qIRV · Pfizer · Infectious Disease
- Other treatment · Novartis Pharmaceuticals · Other
- BNT162b2 vaccine · Vaxxinity, Inc. · Infectious Disease
Not specified - Pf-06804103 · Pfizer · Oncology
- Tumor Tissue · Pfizer · Oncology
- Met097 · Pfizer · Oncology
- Investigational COVID-19 Vaccine · BioNTech · Infectious Disease
- MET233 and MET097 · Pfizer · Other
- Best Available Treatment · Pfizer · Cardiovascular
Not specified on Wikipedia - PF-07836396 Influenza saRNA · Pfizer · Infectious Disease
- Treatment C · Pfizer · Other
- BNT162b2 OMI · Pfizer · Infectious Disease
- PF-06882961 (Cohort 3) · Pfizer · Oncology
- Pf-07999415 · Pfizer · Other
- PF-06939999 dose escalation · Pfizer · Other
- Pf-07284890 · Pfizer · Oncology
- High Dose PF-07328948 · Pfizer · Infectious Disease
- PF-06863135 monotherapy IV or SC · Pfizer Inc.
- PF-07220060 + PF-07104091 combination dose escalation · Pfizer · Oncology
- Ly4064809 · Pfizer · Neuroscience
Not specified on Wikipedia